Fortress Biotech Inc - 9.375% Series A Cumulative Redeemable Pe — Cash Flow (NASDAQ:FBIOP)

Financials

Cash from operating activities 83.68 M116.54 M179.4 M128.22 M80.19 M 66.14 M Cash from investing activities 7.16 M40.51 M22.93 M2.1 M15 M 25.12 M Cash from financing activities 172.41 M148.99 M75.32 M32.74 M70.64 M 97.54 M Free cash flow 80.56 M111.57 M176.69 M123.16 M65.19 M 66.14 M

Fortress Biotech Inc - 9.375% Series A Cumulative Redeemable Pe

Fortress Biotech Inc., commonly known as Fortress Bio, is a biopharmaceutical company that acquires, develops, and commercializes innovative pharmaceutical and biotechnology products. Led by CEO Lindsay A. Rosenwald, M.D., Fortress and most of its subsidiary companies are headquartered in Bay Harbor Islands, Florida.

FBIOP

Financials

Fortress Biotech Inc - 9.375% Series A Cumulative Redeemable Pe

新闻

堡垒生物科技公司重新提交门克斯病治疗药物新药申请

Fortress Biotech, Inc. (FBIO) Q3 2025 Earnings Call Transcript

Fortress Biotech, Inc. (FBIO) Q4 2024 Earnings Call Transcript